Page last updated: 2024-10-18

kynurenine and Hyperparathyroidism, Primary

kynurenine has been researched along with Hyperparathyroidism, Primary in 2 studies

Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.

Hyperparathyroidism, Primary: A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Verheyen, N1
Meinitzer, A1
Grübler, MR1
Ablasser, K1
Kolesnik, E1
Fahrleitner-Pammer, A1
Belyavskiy, E1
Trummer, C1
Schwetz, V1
Pieske-Kraigher, E1
Voelkl, J1
Alesutan, I1
Catena, C1
Sechi, LA1
Brussee, H1
Lewinski, DV1
März, W1
Pieske, B1
Pilz, S1
Tomaschitz, A1
Christensen, MH1
Pedersen, EK1
Nordbø, Y1
Varhaug, JE1
Midttun, Ø1
Ueland, PM1
Nygård, OK1
Mellgren, G1
Lien, EA1

Trials

1 trial available for kynurenine and Hyperparathyroidism, Primary

ArticleYear
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trial.
    Clinical chemistry and laboratory medicine, 2017, Jun-27, Volume: 55, Issue:7

    Topics: Aged; Biomarkers; C-Reactive Protein; Cross-Sectional Studies; Echocardiography; Female; Humans; Hyp

2017

Other Studies

1 other study available for kynurenine and Hyperparathyroidism, Primary

ArticleYear
Vitamin B6 status and interferon-γ-mediated immune activation in primary hyperparathyroidism.
    Journal of internal medicine, 2012, Volume: 272, Issue:6

    Topics: Aged; Biomarkers; Cardiovascular Diseases; Female; Humans; Hyperparathyroidism, Primary; Immunity, C

2012